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Abstract: Background: The hospitalization of patients treated in the intensive care unit (ICU) in 5-15% 
of cases is associated with the occurrence of a complication in the form of ventilator-associated 
pneumonia (VAP). Purpose: Retrospective assessment of risk factors of VAP in patients treated at ICUs 
in the University Hospital in Krakow. Methods: The research involved the medical documentation 
of 1872 patients treated at the ICU of the University Hospital in Krakow between 2014 and 2017. 
The patients were mechanically ventilated for at least 48 h. The obtained data were presented by 
qualitative and quantitative analysis (%). The qualitative variables were compared using the Chi2 
test. Statistically significant was the p <  0.05 value. Results: VAP was demonstrated in 23% of all 
patients treated in ICU during the analyzed period, and this infection occurred in 13% of men and 
10% of women. Pneumonia associated with ventilation was found primarily in patients staying in 
the ward for over 15 days and subjected to intratracheal intubation (17%). A statistically significant 
was found between VAP and co-morbidities, e.g., chronic obstructive pulmonary disease, diabetes, 
alcoholism, obesity, the occurrence of VAP and multi-organ trauma, hemorrhage/hemorrhagic shock, 
and fractures as the reasons for admitting ICU patients. Conclusions: Patients with comorbidities such 
as chronic obstructive pulmonary disease, obesity, diabetes, and alcoholism are a high-risk group for 
VAP. Particular attention should be paid to patients admitted to the ICU with multi-organ trauma, 
fractures, and hemorrhage/hemorrhagic shock as patients predisposed to VAP. There is a need for 
further research into risk factors for non-modifiable VAP such as comorbidities and reasons for ICU 
admission in order to allow closer monitoring of these patients for VAP.
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1. Introduction
Patients treated at intensive care units (ICU) have an increased risk of catching infections. The 
most common of them is ventilator-associated pneumonia (VAP). According to the new definition 
announced by the Center of Disease Control and Prevention (CDC), possible and probable VAP is 
understood as the deterioration of the mechanical ventilation parameters after about two days of stable 
ventilation, resulting in the increase of positive end expiratory pressure (PEEP) by at least 3 mm H2O 
and an increase in FiO2 by at least 20%. Patients have a temperature below 36 °C or above 38 °C and 
leucocytosis (<12,000) or leukopenia (>4000). The definition characterizes a possible VAP if there is 
a purulent secretion in the bronchial tree and a probable VAP if there is an increase in pathogenic 
pathogens in microbiological tests [1].
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According to data from 2014, VAP occurs in about 5-15%  of patients treated in ICUs [2] and 
mortality may be 70% [1]. In the European Centre for Disease Prevention and Control (ECDC) report, 
which included data from 2007 [3], the average incidence was lower than 7%, but the differences between 
European countries were large and ranged from 3% to 36%. In a subsequent ECDC report in 2014, the 
average incidence was 6% [4]. VAP risk factors may be related to the patient's clinical condition, therapy, 
and staff activities [5]. The occurrence of complications is determined by many modifiable factors (e.g., 
body position, sedation, intubation and mechanical ventilation, upper airway instrumentation), as 
well as non-modifiable factors (e.g., age, duration of stay at the ward, comorbidities) [5,6].
Research indicates that the presence of foreign bodies like the endotracheal or gastric tubes are 
the main cause of VAP because they are most easily colonized by pathogenic agents [7- 9]. It is very 
important to learn about other factors—very often unmodified—which predispose the patient to the 
occurrence of VAP (e.g., comorbidities). This knowledge will allow stricter observation of a patient 
who is more predisposed to VAP and enables early diagnosis in the case of emerging VAP symptoms.
Undoubtedly, the occurrence of VAP in a patient treated in ICUs significantly worsens the 
prognosis, increases the costs of treatment, and prolongs the time of hospitalization [5,10,11]. The 
purpose of the study is a retrospective assessment of risk factors of VAP in patients hospitalized in 
intensive care units.
2. Materials and Methods
The study covered 1872 patients hospitalized at the ICU of the University Hospital in Krakow 
between July 2014 to February 2017. In the analyzed period, there were 2059 patients in the ward. The 
inclusion criterion included hospitalization in ICUs for a minimum of two full days, therefore, 187 
patients who were in the ward for a shorter time were not included in the study. The assessment was 
carried out on the third, eighth and fifteenth days of hospitalization.
The study used the analysis of medical records, which were the patients' disease histories and 
TISS (therapeutic intervention scoring system) observation cards. The data was collected using a 
personal questionnaire.
The analysis criterion included gender, age, diagnosis, and co-morbidities. The analysis also 
included data on airway instrumentation in patients, the type and frequency of evacuated secretion, 
the presence of the oropharyngeal tube and the gastric tube, information on the length of intubation, 
duration of mechanical ventilation, and VAP diagnosis.
VAP was diagnosed following the definitions created by the CDC as well as the ECDC, taking 
into account microbiological diagnoses [12- 14]. Permission to conduct the study was obtained from 
the Director of the University Hospital in Krakow, and all analyses of medical documentation were 
performed according to ethical standards and the principles of the Declaration of Helsinki.
The results were presented by qualitative and quantitative analysis (%). The qualitative variables 
were compared using the Chi2 test. The p <  0.05 value was assumed to be statistically significant.
3. Results
In the analyzed group, men prevailed n =  1094 (58%) in relation to women n =  778 (42%). The 
length of stay (LOS) in ICUs varied between 3 to 69 days. The average LOS of the respondents at the 
ICU was 3346 man-days. The average duration of the women's stay was shorter than that of the men's. 
The most common co-morbidities occurring among the studied patients were arterial hypertension n =  
1216 (65%), diabetes n =  709 (38%), obesity n =  290 (15%), atherosclerosis n =  211 (11%), alcoholism n =  
201 (11%), thromboembolism n =  161 (9%), and COPD n =  74 (4%). The characteristics of the studied 
group are presented in Figures 1 and 2.
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Figure 2. Percentage distribution of age of the respondents.
Data analysis showed a statistical significance between the length of hospitalization and the 
occurrence of VAP. The most common diagnosis was in patients staying in the ward for over 15 days 
(17%). In the group of patients treated within 3 -7  days, only 1% were diagnosed with VAP.
In the group* of analyzed comorbidities, highly statistically significant associations were found 
between the occurrence of such diseases as obesity, alcoholism, dibbetes, and COPD and VAP (Table 1 ).
Table 1. Occurrence of VAP in selected comorbidities.
VAP
Comorbidities Yes No P










































COPD—chronic obstructive pulmonary disease, p—significance level, n—number of p atients, %—percent.
Also, the reasons for admission to the ICU have proven to be important in light of the possibility 
of VAP. The analysis showed a statistical significance between the occ urrcure of VAP and multi-organ 
injury (p u 0 .0 0 0 ) , fractures (p =  0.000) , and hemarrhagic/hemorrhagic shock (pi =  0.000), as direct causes 
of admitt ing patients to the I CU (Table 2).
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Table 2. The occurrence of VAP vs. the cause of entering the ICU.
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ICU—intensive care unit, p—-significance level, n—number of patients, %—percent.
Ventilator-associated pneumonia occurred in the majority of patients hospitalized due to the
above-mentioned factors.
There was no statistically significant correlation between the presence of the oropharyngeal tube 
in intubated patients and the occurrence of VAP. The complication related to 1% of subjects (Table 3).
Table 3. The occurrence of VAP vs. the presence of an oropharyngeal tube in intubated patients.
Presence of Oropharyngeal Tubes
VAP Occurrence
Total PYes No
n % n % n %
Yes 26 1 868 24 894 25
No 360 9 2434 66 2794 75 0.003
Total 386 10 3302 90 3688 100
VAP—pneumonia associated with mechanical ventilation, p—significance level, n—number of patients, %—percent.
An extremely important issue was the type of airway instrumentation, and its relationship with 
the occurrence of VAP turned out to be statistically significant (p =  0.047; Table 4).
Table 4. Occurrence of VAP vs. the type of airway breathing assist apparatus.











Intubation 95 6 1315 88 1410 94
Tracheotomy 1 >0.5 83 6 84 6 0.047
Total 96 6 1398 94 1494 100
VAP—pneumonia associated with mechanical ventilation, p—significance level, n—number of patients, %—percent.
4. Discussion
Based on the results of our personal research, it has been shown that many factors influence the 
occurrence of pneumonia associated with mechanical ventilation in ICUs. These are mainly due to 
mechanical ventilation, airway instrumentation, and length of hospitalization. Similar results were 
provided by Bobik and Siemiątkowski [15], who showed that VAP occurs in 8-28%  of mechanically 
ventilated patients. Furthermore, in patients treated at the ICU, this percentage increases to 27-30% , 
increasing the risk of complications by 3 to 10 times. The mentioned authors also showed that the use 
of mechanical ventilation and intubation causes a 21-fold increase in the incidence of VAP, and the risk 
increases steadily with each day of mechanical ventilation.
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In our own study, it was shown that the length of hospitalization and the time of using mechanical 
ventilation had a significant influence on the occurrence of VAP. Similar results were presented by 
Karpel [16], which shows that the increased risk of VAP is dependent on the length of mechanical 
ventilation, and Szeter [17], indicating an increased risk of VAP by 1-3%  for each day of mechanical 
ventilation. Also, the results of the research presented by Kubisz [18] are similar to the results of their 
own reports. The author emphasizes that when ICU hospitalization is prolonged beyond 72 h, the risk 
of pneumonia increases 12-fold.
In Rosenthal et al. [19], a report from 50 countries on VAP incidences ranged from 0.9 and 13.1 
per 1000 ventilator-days. Ventilator-associated pneumonia density in the American CDC NHSN 
program from 2012 was, on average, 0.9 per 1000 ventilator-days [20]. In European countries, in a 
study published in 2012, the mean density of VAP was 8 in 1000 with intubation [1]. In another earlier 
study of Rosenthal et al., a report from 55 ICUs from 46 hospitals showed VAP incidences ranged from 
10.0 to 52.7 per 1000 ventilator-days (the countries of southern America, Turkey, India) [21].
Noteworthy are the results regarding the relationship between co-morbidities and the occurrence 
of VAP. In the VAP study, this was found more frequently in patients with co-existing COPD, alcoholism, 
diabetes, and obesity. In the study by Rajnan et al. [22], VAP occurred in 57% of patients with diagnosed 
COPD. The results presented by Blot showed a relationship between the occurrence of VAP and 
diabetes [23].
In our study, there was a correlation between the reason for patient ICU admission and the 
occurrence of VAP. Patients with multi-organ trauma, hemorrhage/hemorrhagic shock and fractures 
more often suffered from VAP. The results of studies by Rajnan N. et al. [22] have also shown that the 
risk of developing VAP in patients with trauma was 76%.
There is a relationship between the type of airway instrumentation and the incidence of VAP. 
Patients with an inserted endotracheal tube are more likely to develop VAP than patients with a 
tracheotomy. In our research, pneumonia was more common in intubated patients (6%) than those 
with a tracheotomy (less than 0.5%). On the fifteenth day of hospitalization, VAP was diagnosed in the 
majority of intubated patients. Similar results were obtained in the research studies by Karaoglan et 
al. [24] in which the risk of VAP increased 7-fold among VAP patients, and 3-fold among patients with 
tracheotomies. Pirozynski et al. [25] showed similar relationships in their studies. He stressed that the 
patient's intubation is one of the highest risk factors for VAP. According to the authors, the chances of 
the occurrence of pneumonia in the case of intubated patients increases by as much as 6 to 21 times.
In our study, there was no correlation between the presence of the oropharyngeal tube and VAP 
risk. In 1% of the patients intubated and in the gyroconeal section, VAP was diagnosed, while 24% 
were hospitalized with a laryngeal tube but did not have VAP.
The lack of association between the occurrence of pneumonia in patients treated in the ICU and the 
presence of laryngeal tubes may be associated with nurses administering oral cleaning in accordance 
with established procedures [23- 25].
5. Conclusions
There is a need for further research into the risk factors of non-modifiable VAP, such as 
comorbidities, and the reasons for admission to ICUs in order to allow closer monitoring of these 
patients for VAP.
1. Patients with acute respiratory failure, multi-organ trauma, fractures, or hemorrhage/hemorrhagic 
shock are groups with a predisposition to the occurrence of VAP.
2. Particular attention should be paid to patients with comorbid COPD, obesity, diabetes, or 
alcoholism as high-risk groups for VAP.
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